Gilead teams up with Terray for AI-powered drug discovery, leveraging Terray’s tNova platform to accelerate the development ...
The Breakout clinical trial enrolled 16 patients with type 2 diabetic nephropathy, with 8 patients completing the full ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback